Skip to main content
Loading

SciTech Development

February 26, 2024
Oncology
SciTech Development
SciTech is a clinical-stage oncology-focused drug delivery technology company. Our initial clinical trial is underway with IRB-approved sites at UPMC, Columbia University, MD Anderson, USC, U Michigan, and Karmanos Cancer Institute. SciTech's mission is to develop safe oncology therapeutics that significantly improve patient outcomes.
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP